Trial Profile
A Prospective Trial to Evaluate the Effectiveness of Clopidogrel to Relieve Migraine With Right-to-left Shunt
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 04 Oct 2023
Price :
$35
*
At a glance
- Drugs Clopidogrel (Primary)
- Indications Migraine
- Focus Therapeutic Use
- 23 Aug 2021 Planned End Date changed from 1 Oct 2018 to 1 Oct 2023.
- 23 Aug 2021 Planned primary completion date changed from 1 Oct 2017 to 1 Oct 2023.
- 23 Aug 2021 Status changed from not yet recruiting to recruiting.